bitBiome Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 20

bitBiome General Information

Description

Developer of microbial genome analysis technology designed to discover and engineer enzymes, pathways, and microbial strains for bio-based manufacturing. The company offers single-cell microbial genome analysis technology, a large microbial sequence database, and bioinformatics and machine learning capabilities, enabling biomanufacturing companies to develop and produce nature-inspired bio-based products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Waseda University Building 121, Research Innovation Center Room 415
  • 513 Waseda Tsurumaki-cho, Shinjuku-ku
  • Tokyo, 162-0041
  • Japan
+81
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Corporate Office
  • Waseda University Building 121, Research Innovation Center Room 415
  • 513 Waseda Tsurumaki-cho, Shinjuku-ku
  • Tokyo, 162-0041
  • Japan
+81

bitBiome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

bitBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 26-May-2026 Completed Generating Revenue
8. Accelerator/Incubator 15-Jul-2025 Completed Generating Revenue
7. Later Stage VC 17-Jan-2025 Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator 26-Mar-2024 Completed Generating Revenue
3. Later Stage VC (Series 1) 31-Jul-2023 Completed Generating Revenue
2. Early Stage VC (Series B) 24-Aug-2020 $6.89M $10.1M Completed Generating Revenue
1. Seed Round 09-Jan-2019 $3.16M $3.16M Completed Generating Revenue
To view bitBiome’s complete valuation and funding history, request access »

bitBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B2
Class B
Class A 175,000 $12.72 $12.72 1x $12.72 22.31%
To view bitBiome’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

bitBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbial genome analysis technology designed to discover and engineer enzymes, pathways, and microbial str
Other Pharmaceuticals and Biotechnology
Tokyo, Japan
52 As of 2026

New York, NY
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

bitBiome Competitors (2)

One of bitBiome’s 2 competitors is Schrodinger, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Schrodinger Formerly VC-backed New York, NY
Ginkgo Bioworks Formerly VC-backed Boston, MA
You’re viewing 2 of 2 competitors. Get the full list »

bitBiome Patents

bitBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260337600-A1 Highly efficient method for obtaining gene sequence Pending 04-Oct-2022
WO-2024075787-A1 Highly efficient method for obtaining gene sequence Inactive 04-Oct-2022
JP-2025103056-A Polypeptide and application of the same Pending 04-Mar-2022
WO-2023167311-A1 Polypeptide and use thereof Inactive 04-Mar-2022
JP-2025081784-A Method for identifying amino acid residue sequence, program and recording medium Pending 01-Mar-2022
To view bitBiome’s complete patent history, request access »

bitBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

bitBiome Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Valuence Ventures Venture Capital Minority
Pegasus Tech Ventures Corporate Venture Capital Minority
Darwin Venture Management Venture Capital Minority
Global Brain Venture Capital Minority
In-Q-Tel Not-For-Profit Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

bitBiome FAQs

  • When was bitBiome founded?

    bitBiome was founded in 2018.

  • Where is bitBiome headquartered?

    bitBiome is headquartered in Tokyo, Japan.

  • What is the size of bitBiome?

    bitBiome has 52 total employees.

  • What industry is bitBiome in?

    bitBiome’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is bitBiome a private or public company?

    bitBiome is a Private company.

  • What is bitBiome’s current revenue?

    The current revenue for bitBiome is .

  • How much funding has bitBiome raised over time?

    bitBiome has raised $16.1M.

  • Who are bitBiome’s investors?

    Valuence Ventures, Pegasus Tech Ventures, Darwin Venture Management, Global Brain, and In-Q-Tel are 5 of 20 investors who have invested in bitBiome.

  • Who are bitBiome’s competitors?

    Schrodinger and Ginkgo Bioworks are competitors of bitBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process